Back

A prehabilitation programme is feasible and acceptable for mild-to-moderately frail patients undergoing cardiac surgeries

31 August 2024 (17:00 - 17:50)
Organised by: Logo
Congress Presentation Part of: Cardiac surgery and rehabilitation Chronic Nursing Care ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Assistant Professor Polly Li

The University of Hong Kong, Hong Kong (Hong Kong)

7 More presentations in this session

Presentation thumbnail
Healthcare professionals' experiences of the usefulness and ease of using a digital medical translation tool in communicating with minority language-speaking hospitalized heart surgery patients
Professor I. Lie (Oslo, NO)
Abstract Slides Video
Presentation thumbnail
Patient control preferences prior to discharge after cardiac surgery
Professor R. Wynne (Melbourne, AU)
Abstract Slides Video
Presentation thumbnail
Factors influencing hospital stay duration in an elective cardiac surgery cohort
Doctor M. Verdugo-Marchese (Gland, CH)
Abstract Slides Video
Presentation thumbnail
Cardiac rehabilitation ambassadors - a new model to enhance patient participation
Mrs J. Kevill (Camberwell, AU)
Abstract Slides Video
Presentation thumbnail
Nutritional management, skipping breakfast, glycemic control, and cardiovascular risk on type 2 diabetes mellitus
Doctor T. Minari (Sao Paulo, BR)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiac surgery and rehabilitation

The Event

Event poster

ESC Congress 2024

31 August 2024 17:00 CET
You may be interested in
thumbnail
Congress Presentation
Cardiac prehabilitation in patients awaiting cardiac surgery: a multidisciplinary strategy for optimized outcomes
thumbnail
Congress Presentation
Systematic review and meta-analysis on the effects of physical activity-based interventions on frailty status and clinical outcomes in adults with long-term cardiac conditions.
thumbnail
Congress Presentation
Perioperative rehabilitation in patients undergoing elective cardiac valve surgery--a randomised controlled trial.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources